Safety and Pharmacodynamic Study of CD-NP

NCT00482937 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure, Congestive

Interventions

DRUG: CD-NP

Sponsor

Nile Therapeutics